Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
Jauw YW, Menke-van der Houven van Oordt CW, Hoekstra OS, Hendrikse NH, Vugts DJ, Zijlstra JM, Huisman MC, van Dongen GA. Jauw YW, et al. Among authors: van dongen ga. Front Pharmacol. 2016 May 24;7:131. doi: 10.3389/fphar.2016.00131. eCollection 2016. Front Pharmacol. 2016. PMID: 27252651 Free PMC article. Review.
[Radio-immunotherapy for B-cell non-Hodgkin lymphoma].
Visser OJ, Zijlstra JM, van Dongen GA, Huijgens PC. Visser OJ, et al. Among authors: van dongen ga. Ned Tijdschr Geneeskd. 2005 Oct 15;149(42):2324-8. Ned Tijdschr Geneeskd. 2005. PMID: 16261710 Review. Dutch.
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA. Börjesson PK, et al. Among authors: van dongen ga. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2133-40. doi: 10.1158/1078-0432.CCR-05-2137. Clin Cancer Res. 2006. PMID: 16609026
Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.
Rizvi SN, Visser OJ, Vosjan MJ, van Lingen A, Hoekstra OS, Zijlstra JM, Huijgens PC, van Dongen GA, Lubberink M. Rizvi SN, et al. Among authors: van dongen ga, van lingen a. Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):512-20. doi: 10.1007/s00259-011-2008-5. Epub 2012 Jan 5. Eur J Nucl Med Mol Imaging. 2012. PMID: 22218876 Free PMC article. Clinical Trial.
237 results